Qiu Fang Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qiu Fang Jia has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Cai Xia Jiang
Institute of Mental Health, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China
2 shared publicationsGuang Zhong Yin
Institute of Mental Health, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China
2 shared publications- Li Hui
Suzhou Guangji Hospital, the Affiliated Guangji Hospital of Soochow University, Suzhou, China
2 shared publications Xu Yuan Yin
Institute of Mental Health, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China
2 shared publicationsZheng Kang Qian
Institute of Mental Health, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, Soochow University, No. 11 Guangqian Road, Suzhou, 215137, Jiangsu, People's Republic of China
2 shared publicationsEric F. C. Cheung
Castle Peak Hospital, Hong Kong, People's Republic of China
1 shared publication
Latest Publications
- 1 April 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 218, 295-297
Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia
- 1 April 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 218, 295-297
Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia
- Open Access
- 25 November 2019
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 7 (1) , 1-7
Association between decreased HDL levels and cognitive deficits in patients with bipolar disorder: a pilot study
Background: Cognitive deficits are common in patients with bipolar disorder (BD). Abnormal high density lipoprotein (HDL) levels have been implicated in cognitive deficits associated with ageing and neurodegenerative disorders. The present study aimed to investigate serum HDL levels, cognitive deficits and their association in patients with BD.Methods: Thirty-seven patients with BD and 37 gender- and age-matched healthy controls (HCs) were recruited in a case–control study. Cognition was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and serum HDL levels were measured using enzymatic colourimetry.Results: There was no difference in serum HDL levels between patients with BD and HCs after adjusting for gender, age, education and body mass index (BMI). Cognitive test scores in patients with BD were significantly lower than those in HCs except for the visuospatial/constructional index after adjusting for confounding variables. Serum HDL levels were positively correlated with RBANS total score and language score in patients with BD. Stepwise multiple regression analysis showed that serum HDL levels were significantly correlated with RBANS total score and subscale scores on immediate memory and language in patients with BD after adjusting for confounding factors.Conclusions: Our findings suggest that patients with BD had poorer cognitive performance than HCs except for the visuospatial/constructional domain, and decreased serum HDL levels were correlated with cognitive deficits, especially in immediate memory and language domains in patients with BD.
- 25 November 2019
- Published by Springer Nature in International Journal of Bipolar Disorders
- Vol. 7 (1) , 1-7
Open AccessAssociation between decreased HDL levels and cognitive deficits in patients with bipolar disorder: a pilot study
Background: Cognitive deficits are common in patients with bipolar disorder (BD). Abnormal high density lipoprotein (HDL) levels have been implicated in cognitive deficits associated with ageing and neurodegenerative disorders. The present study aimed to investigate serum HDL levels, cognitive deficits and their association in patients with BD.Methods: Thirty-seven patients with BD and 37 gender- and age-matched healthy controls (HCs) were recruited in a case–control study. Cognition was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and serum HDL levels were measured using enzymatic colourimetry.Results: There was no difference in serum HDL levels between patients with BD and HCs after adjusting for gender, age, education and body mass index (BMI). Cognitive test scores in patients with BD were significantly lower than those in HCs except for the visuospatial/constructional index after adjusting for confounding variables. Serum HDL levels were positively correlated with RBANS total score and language score in patients with BD. Stepwise multiple regression analysis showed that serum HDL levels were significantly correlated with RBANS total score and subscale scores on immediate memory and language in patients with BD after adjusting for confounding factors.Conclusions: Our findings suggest that patients with BD had poorer cognitive performance than HCs except for the visuospatial/constructional domain, and decreased serum HDL levels were correlated with cognitive deficits, especially in immediate memory and language domains in patients with BD.
- 1 December 2018
- Published by Elsevier in Psychiatry Research
- Vol. 270, 438-442
Association between decreased serum albumin levels and depressive symptoms in patients with schizophrenia in a Chinese Han population: A pilot study
- 1 December 2018
- Published by Elsevier in Psychiatry Research
- Vol. 270, 438-442
Association between decreased serum albumin levels and depressive symptoms in patients with schizophrenia in a Chinese Han population: A pilot study